Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Arrowhead Pharma

(NASDAQ: ARWR)
Add to Portfolio
-0.93 (-1.40%)
as of Dec 5, 2019

Last 65.53
Change -0.93 (-1.40%)
Open 66.00
Prev. Close 66.46
Today's Range
62.50
66.77
52wk Range
10.41
73.72
Volume 2,445,900
Avg Volume 3,000,180
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
ARWR -1.40% +131.88% +384.33%
DJIA +0.10% +2.62% +10.59%
S&P 500 +0.15% +4.44% +15.46%

Key Statistics

Annual EPS 0.69
Dividend Yield 0.00%
P/E Ratio 99.51
Market Capitalization, $K 6,571,310
Weighted Alpha +327.40
Standard Deviation -0.22
Profit Margin -107.82%
Beta 2.00

Growth Rates

YTD +427.62%
1-Year +406.17%
3-Year +4,822.96%
5-Year +1,053.82%
10-Year +1,153.96%

Opinion

Sell Hold Buy

Recent Headlines

Arrowhead Pharmaceuticals Announces Pricing of

BusinessWire via COMTEX - Wed Dec 04, 06:00AM EST
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock, offered at a price of $58.00 per share, before underwriting discounts. The offer(full story)
ARWR: 65.53 (-0.93)

Arrowhead Pharma has the Best Relative Performance in

Comtex SmarTrend(R) via COMTEX - Wed Dec 04, 03:27AM EST
We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of(full story)
AKBA: 6.06 (+0.06), SGMO: 11.59 (-0.11), ARWR: 65.53 (-0.93)

Arrowhead Pharmaceuticals Announces Proposed

BusinessWire via COMTEX - Mon Dec 02, 04:05PM EST
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced its intention to offer and sell 4,000,000 shares of its common stock in an underwritten offering pursuant to its existing automatic shelf registration statement. All of(full story)
ARWR: 65.53 (-0.93)

Akebia Therapeut has the Best Relative Performance in

Comtex SmarTrend(R) via COMTEX - Mon Dec 02, 03:28AM EST
Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.(full story)
ADMS: 6.52 (+0.12), AKBA: 6.06 (+0.06), BPMC: 74.56 (-0.54), ARWR: 65.53 (-0.93)

Top 5 Companies in the Biotechnology Industry with the

Comtex SmarTrend(R) via COMTEX - Fri Nov 29, 03:29AM EST
Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.(full story)
CLVS: 8.86 (-3.26), GBT: 76.15 (+1.97), INSM: 22.57 (-0.79), ARWR: 65.53 (-0.93)